retatrutide legal status vs Ozempic: Clinical Trial Comparisons Retatrutide Triple Hormone Receptor Agonist:

For a comprehensive overview of all retatrutide side effects and management strategies, see our complete side effects guide

Rather than suppressing caloric intake, they may enhance substrate utilization, preserve lean mass, and improve metabolic resiliencefeatures particularly relevant to aging populations, where sarcopenia, osteoporosis, and insulin resistance frequently coexist

Lowering Systemic Inflammation Excess body fat promotes a state of chronic, low-grade inflammation

Rapid changes in food intake, hydration, and glucose patterns can create avoidable risks

Trademark Acknowledgment: Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S